Gynecological Cancer
- Liver, Lung, Melanoma, skin, Other Female GenitalPhase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Melanoma or Endometrial CarcinomaPrincipal Investigator: Mario Sznol
- Corpus UteriA Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial CancerPrincipal Investigator: Alessandro Santin
- Other Female Genital, OvaryA Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or PeritoneumPrincipal Investigator: Gary Altwerger
- Corpus UteriA Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate, in Patients With Persistent or Recurrent Endometrial CarcinomaPrincipal Investigator: Alessandro Santin
- Other Endocrine System, Other Female GenitalEndometrium and MetabolismPrincipal Investigator: Clare Flannery